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Rabbit haemorrhagic disease (RHD) is a highly infectious and fatal
disease of the European rabbit (Oryctolagus cuniculus). It was ﬁrst
described in China (Liu et al., 1984), then subsequently in most parts
of the world affecting domestic rabbits and also wild populations. The
etiological agent of the disease, the Rabbit hemorrhagic disease virus
(RHDV), is a non-enveloped single-stranded positive-sense RNA virus
belonging to the genus Lagovirus (Green et al., 2000) of the family
Caliciviridae (Meyers et al., 1991; Ohlinger et al., 1990; Parra and
Prieto, 1990; Rasschaert et al., 1995).
Several works have serologically evidenced non-pathogenic
RHDV-like strains in Europe (Capucci et al., 1997; Chasey et al.,
1997; Marchandeau et al., 1998; Rodak et al., 1990; Trout et al., 1997)
and also in Australia or New Zealand (Bruce and Twigg, 2004; Bruce et
al., 2004; Nagesha et al., 2000; O'Keefe et al., 1999; Parkes et al., 2002;Robinson et al., 2002). The existence of non-pathogenic RHDV strains
was established in 1996, when a non-lethal RHDV-like strain
genetically distinct from RHDV and called rabbit calicivirus (RCV)
was isolated in a rabbitry in Italy (Capucci et al., 1996). This strain
differs from the RHDV by its tissue tropism, viral load and the
sequence of the gene encoding the capsid protein. Subsequently,
apparently non-pathogenic strains were detected after isolation of
viral RNA fragments in healthy domestic or wild rabbits from the UK
and Ireland (Forrester et al., 2007, 2009; Moss et al., 2002). Lastly, a
recent report identiﬁed another non-pathogenic lagovirus named
RCV-A1 in three apparently healthy young wild Australian rabbits
(Strive et al., 2009). The Italian RCV and the Australian RCV-A1 are the
only two viruses whose non-lethality has been experimentally
conﬁrmed (Capucci et al., 1996; Strive et al., 2010). For all the other
strains non-pathogenicity is assumed owing to their isolation in
healthy non-vaccinated rabbits. A phylogenetic analysis of RHDV and
genetically related non-pathogenic strains based on a fragment of the
capsid protein nucleotide sequence showed three distinct genetic
groups (Strive et al., 2009). Besides the ﬁrst group that contains RHDV
strains, the second one contains RCV, the Lambay strain from Ireland,
Table 1
Antibody responses in the 60 rabbits used in this study.
Rabbit* Serology D0 Serology D6 Serology D13
VP60-ELISA† VP60-ELISA cELISA IgG IgA IgM VP60-ELISA
AR02 + ++++
AR04 ++ ++++
AR06‡ − ++++ b10 80 b10 b10
AR08‡ ++ ++ b10 40 b10 b10
AR10 ++ ++
AR12‡ − +++ b10 40 b10 b10
AR14 ++ ++++
AR16 ++ ++++
AR18 +++ ++++
AR20 +++ ++++
AR26‡ − ++++ b10 40 b10 b10
AR28‡ − + b10 40 b10 b10
AR30 ++ ++++
AR32‡ − ++++ b10 80 b10 b10
AR34 − ++++
AR36‡ − ++++ b10 40 b10 b10
AR38‡ − +++ b10 40 b10 b10
AR40‡ − ++++ b10 40 b10 b10
AR42‡ − ++++ b10 b10 b10 b10
AR44 + ++++
AR46 − ++++
AR48‡ − +++ b10 40 b10 b10
AR50 − ++
AR52 +++ ++++
AR54‡ − +++ b10 b10 b10 b10
AR56 − ++++
AR58‡ − ++++ b10 b10 b10 b10
AR60 − ++++
AR62‡ − ++++ b10 160 b10 b10
AR64 − ++++
JA1611§ − - −
JA1613‡ + +++ b10 b10 b10 b10
JA1615‡ − +++ b10 b10 b10 b10
JA1617 − − +
JA1619 ++ ++
JA1621 − − ++
JA1623 − − ++
JA1625 − + +
JA1627 +++ ++++
JA1629 ++ ++++
JA1631 − + ++
JA1633 ++ ++
JA1635§ − + +
JA1637§ − − −
JA1639 ++ ++++
JA1641§ − − −
JA1651‡ − ++++ b10 b10 b10 b10
JA1653‡ − ++++ b10 b10 b10 b10
JA1655 ++ ++++
JA1657‡ + +++ b10 b10 b10 b10
JA1659 ++ ++++
JA1663 ++ ++++
JA1665‡ − +++ b10 b10 b10 b10
JA1667‡ − ++ b10 b10 b10 b10
JA1669‡ − +++ b10 b10 b10 b10
JA1671§ − − −
JA1684 ++ ++++
JA1686 + ++++
JA1688‡ − +++ b10 80 b10 b10
JA1690‡ − +++++ b10 b10 b10 b10
*The rabbit number corresponds to the location where the rabbit was placed in
quarantine (“AR” or “JA”) followed by an order number. Numbers in italics and in bold
correspond to the rabbits used for the experimental study of protection against RHDV
challenge (ﬁve rabbits). A number in italics, in bold and underlined corresponds to the
rabbits remained in the “JA” location that died from a natural RHD between D19 and
D22 (9 rabbits). The number in a grey box (JA1641) corresponds to the rabbit from
which the strain 06-11 was identiﬁed and characterised.
†Serological status determined using VP60-RHDV ELISA. The scoring system is
described in materials and methods section.
‡The serum was also screened with competitive ELISA (cELISA) and anti-isotype ELISA
tests (Capucci et al., 1997; Cooke et al., 2000; Lavazza and Capucci, 2008a). b10:
negative; 40–160: positive with a low titre. The corresponding rabbits were sacriﬁced
at D13 for virological analysis (24 rabbits).
§ The rabbit were sacriﬁced at D21 for virological analysis (5 rabbits).
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Australian RCV-A1. These two last groups contain non-pathogenic
strains except perhaps the Ashington strain, presumed to be a
pathogenic virus although its pathogenicity has not been experimen-
tally proved (Moss et al., 2002). For the non-pathogenic viruses that
are genetically related but relatively distant to pathogenic RHDV (i.e.,
the Italian RCV, the Irish Lambay strain, the English Ashington strain
and the Australian RCV-A1) Kerr et al. (2009) proposed the name
rabbit calicivirus-like (RCV-like) viruses to distinguish them from
RHDV. However, since these viruses are all caliciviruses, it would be
better to describe them as non-pathogenic rabbit calicivirus or
lagovirus. In addition, a recent study suggested that as RCV and
similar strains did not form a monophyletic group with RCV-A1, the
name RCV-like was not appropriate for these viruses (Jahnke et al.,
2010). We have therefore chosen the name non-pathogenic lagovirus
(NP-LV) to designate them.
Competitionbetweennon-pathogenic andpathogenic strains and the
possible role of the non-pathogenic strains in reducing the impact of RHD
have been discussed by several authors on the basis of cross-protection
between strains (Boots et al., 2004; Cooke et al., 2000, 2002; Robinson
et al., 2002; White et al., 2001). However, the protection conferred by
antibodies induced by some NP-LV is lower than that conferred by
antibodies inducedby virulent RHDVor RCV (Cooke et al., 2002;Nagesha
et al., 2000; Strive et al., 2010). Otherwise, a French study based on
serological data showed that antibodies produced in response to some
NP-LV strainsmay not protect against RHDV (Marchandeau et al., 2005).
These results suggest that study of the competition between strains
needs to take into account the existence of non-protective or slightly
protective strains, which requires a sufﬁcient knowledge of the diversity
of the circulating strains.
In the present work, we have identiﬁed a new infectious lagovirus
related to RHDV from healthy domestic rabbits and determined the
sequence of the gene encoding the VP60 capsid protein in order to
establish phylogenetic relationships with other rabbit lagoviruses. In
addition, we have investigated its non-lethality for speciﬁc pathogen
free (SPF) rabbits and the degree of cross-protection induced by the
antibodies due to this viral strain against a lethal RHDV challenge.
Results
Serological status of the rabbits
The VP60-RHDV ELISA test performed on sera from 60 healthy 10-
week-old rabbits from the rabbitry revealed that 38% of them were
seropositive at D0 and 88% 1 week later, indicating that an active
infection was in progress in the rabbitry (Table 1). Sera from 24
rabbits seropositive at D6 and sacriﬁced for virological screening at
D13 were tested with the cELISA and anti-isotype ELISA tests speciﬁc
to RHDV. None were positive by cELISA, IgM, or IgA ELISA (b10), but
some of them showed low levels of IgG (40–160) (Table 1). According
to Cooke et al. (2000), these last rabbits (cELISA titres ≤ 10, with
moderate IgG antibodies but without IgA or IgM) were considered to
have been infected with a non-pathogenic lagovirus. Therefore, the
antibodies detected with the VP60-RHDV ELISA test were not speciﬁc
to pathogenic RHDV.
Sequence analysis of the capsid protein
Duodenum samples gave the ﬁrst positive RT-PCR results when
liver or spleen samples gave negative results. We therefore focused on
duodenum samples to continue the search for viral RNA. Nineteen of
the 29 duodenum intestines samples tested were positive and PCR
product sequencing results conﬁrmed that they were close to rabbit
lagovirus sequences. Among the PCR-positive samples, sample JA1641
(strain 06-11) was subjected to a full-length VP60 PCR ampliﬁcation
and the PCR product was sequenced.
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acids long) and when compared to RHDV, has a 6 nt deletion in length
at position 921–927 which corresponds to the amino acids (aa) 308
and 309 of the VP60 protein of RHDV. A similar deletion is present at
the same location in the Ashington strain genome and at aa 309 and
310 in the RCV genome. The average nucleotide identity between the
VP60 gene sequences of 06-11 and RHDV is 83%. The 06-11 strain
shared 85% identity with RCV but only 79% with the non-pathogenic
RCV-A1. In contrast, this identity reached 93.8% with the Ashington
sequence available in nucleotide databases (1542 nt/1644 nt
identity).
The 06-11 VP60 deduced amino acid sequence was aligned with
those of some RHDV reference strains including one antigenic variant
RHDVa strain, RCV, Ashington and RCV-A1 (Fig. 1). The average amino
acid similarity between 06-11 and RHDV is 90.8%. It is 92.9% with RCV,
87% with RCV-A1 and 97.8% with the Ashington sequence. The
majority of the 06-11 substitutions (83%) are located in the most
variable part of the capsid protein, the C-terminal half. When we
compared the sequenceswithin the two regions that show the highest
degree of genetic variation (region C from aa 301 to 310 and region E
from aa 344 to 434, according to the nomenclature of Neill (1992)),
similarities decreased to about 81.2%, 79.2%, or 63.4%, between 06-11
and RHDV, RCV, or RCV-A1, respectively. These data emphasised the
differences between the viruses. On the contrary, the similarity
between the 06-11 and Ashington sequences reached 95%, and even
100% within the hypervariable region C which also contains the two
amino acid deletions.Genetic relationship
Irrespective of the method used, phylogenetic analyses imple-
mented with the almost entire capsid protein nucleotide sequences of
RCV-A1, 32 RHDV and RCV isolates gave similar results. They revealed
that the rabbit lagoviruses were clustered into three major genetic
groups, (i) a group comprised of the pathogenic RHDV strains further
separated into viruses related to the prototype RHDV and the
antigenic variant RHDVa, (ii) a group comprised of the RCV strain
together with the Ashington strain and the 06-11 strain described in
this study, and (iii) a group comprised of RCV-A1 strain alone (Fig. 2).
We noticed that the RCV, Ashington and 06-11 viruses showed
signiﬁcant genetic variation from each other and from the RHDV
sequences.Experimental evidence of a replicating non-lethal lagovirus
An experimental study was performed to test whether the 06-11
strain could be transmitted by inoculation or through contact from
NP-LV infected rabbits to serologically naïve SPF rabbits without
causing disease. Serological analyses using the VP60-RHDV ELISA test
conﬁrmed that, at the beginning of the assay, the two SPF rabbits were
seronegative and the three domestic rabbits were seropositive with
low to moderate titres. The presence of antibodies was detected in the
blood sample collected as early as D5 from the SPF rabbit in close
contact with the three domestic rabbits (low titre) and in the blood
sample collected at D10 from the inoculated SPF rabbit (moderate
titre). No sign of RHD was detected during the assay, and at necropsy
no lesions were seen. Screening for NP-LV RNA was performed in
duodenum samples collected from the ﬁve rabbits at the sacriﬁce. We
succeeded in amplifying a DNA fragment of the expected size for all
the rabbits (PCR U38-L337). The VP60 sequence determined from the
SPF rabbit samples was identical to the sequence of the NP-LV strain
06-11 previously established. Thus, we conﬁrmed that this virus can
be experimentally transmitted to SPF rabbits without causing clinical
signs or mortality.Field and experimental evidences of a lagovirus that induces non-
protective antibodies
In “JA” location, a natural RHD outbreak occurred at D19 in one
hutch where 10 seropositive rabbits, showing moderate to very high
antibody levels at D6 (Table 1), were kept and fed with grass taken
from a RHDV-contaminated area. Nine rabbits died within 4 days. At
necropsy typical RHD lesions were observed and all the sampled livers
were RHDV-positive by RT-PCR test.
In order to experimentally determine whether the NP-LV
antibodies detected by the VP60-RHDV ELISA test conferred cross-
protection to rabbits against subsequent infection with RHDV, an
infection study was performed on ﬁve seropositive rabbits with very
high antibody levels (Table 1). Three rabbits were challenged with an
intramuscular inoculation of a dose of RHDV commonly used to check
the efﬁcacy of commercial vaccines and died 2–4 days post-infection.
The two non-inoculated rabbits placed in contact in an adjacent cage
died 4–6 days post-infection. These rates and timeframes of mortality
for inoculated or contact animals are consistent with the expected
results following the standard viral challenge on immunologically
naïve rabbits. By comparison, vaccinated rabbits exhibiting even low
RHDV antibody levels as determined with VP60-RHDV ELISA were
shown to be protected against the challenge dose used in this study
(Bertagnoli et al., 1996). At necropsy typical RHD lesions were
observed and all the sampled livers were RHDV-positive by RT-PCR
test.
Discussion
The observation of a spontaneous serological conversion of rabbits
more than 2 months old, i.e., without maternal antibodies and having
become sensitive to RHD, showed that an active infection was in
progress in the rabbitry. The absence of associated mortality
suggested that a non-pathogenic virus serologically related to RHDV
was responsible for these seroconversions. A similar overall clinical
picture previously led to the characterisation of the RCV in an Italian
industrial rabbitry (Capucci et al., 1996). In the present study,
experimental investigation showed that the virus is highly infectious
as described for RHDV, but non-lethal for rabbits. We could not
assume that it is deﬁnitively a non-pathogenic virus since we did not
histologically examined the representative organs of died rabbits.
Thus, we cannot exclude that histological changes may be evident
even in the absence of macroscopic changes. Future histological
studies will be necessary to clearly demonstrate the lack of
pathogenicity of this virus. However, the name of non-pathogenic
has been commonly used to characterise the non-lethal lagoviruses
isolated in healthy rabbits such as RCV or RCV-A1 even when no
histological studies have been performed.
We also conﬁrmed that, in contrast to the RCV or RCV-A1, the
antibodies raised against this strain irrespective of their titre do not
protect against RHDV. Indeed, a total of 14 out 15 seropositive rabbits
died from RHD, including the nine remained in one of the quarantine
locations which died following a natural RHDV infection. In a previous
study conducted during a RHDV outbreak in a free-living population
of rabbits, we observed that some rabbits died from RHD even if they
were seropositive for anti-RHDV antibodies and had expected
protective titres (Marchandeau et al., 2005). Some recent molecular
data proving the circulation of closely related NP-LV strains in French
wild rabbit populations (unpublished results) are in agreement with
the present results. Indeed, it is conﬁrmed the hypothesis initially
proposed, i.e., these detectable but non-protective antibodies were
induced by an NP-LV infection.
We have identiﬁed a lagovirus (06-11 strain), which differs from
the RHDV strains in terms of pathogenicity, but also in terms of tissue
tropism (small intestine) and sequence of the VP60 capsid protein.
These characteristics are consistent with ﬁndings on RCV and RCV-A1.
10        20        30        40        50        60        70        80        90       100
|         |         |         |         |         |         |         |         |         |
FR-88   MEGKARAAPQGEAAGTATTASVPGTTTDGMDPGVVATTSVITAENSSASIATAGIGGPPQQVDQQETWRTNFYYNDVFTWSVADAPGSILYTVQHSPQNN
SD-89   ------T---------------------------------V-----------------------------------------------------------
05-01   ------T---SD----------------------------V-T---------------------------------------------------------
Wr-96 ------T----------------------L----------V------------------------------------------VG---------------
95-10   ------T----------------------L----------V-----------------------------------------------------------
Me-93 ------T----R----------------------------V-----------------------------------------------------------
99-05   ------T-----------------------------A---V--------V--------------------------------------------------
RCV     ------IT--------------------------------V-T--A-T-V--------------------------------------------------
06-11 ------IT--------------------------------V-T--A-T----------------------------------------------------
Ash ******************----------------------V-T--A---V--------------------------------------------------
RCV-A1  -------T---DT---------------------------V----A-T-V------------T---------A----------T--------A-------
110       120       130       140       150       160       170       180       190       200
|         |         |         |         |         |         |         |         |         |
FR-88   PFTAVLSQMYAGWAGGMQFRFIVAGSGVFGGRLVAAVIPPGIEIGPGLEVRQFPHVVIDARSLEPVTITMPDLRPNMYHPTGDPGLVPTLVLSVYNNLIN
SD-89   ----------------------------------------------------------------------------------------------------
05-01   ----------------------------------------------------------------------------------------------------
Wr-96   ----------------------------------------------------------------------------------------------------
95-10   ----------------------------------------------------------------------------------------------------
Me-93 ------------------------------------------------------------S---------------------------------------
99-05   ----------------------------------------------------------------------------------------------------
RCV     ----------------------------------------------------------------------------------------------------
06-11 ----------------------------------------------------------------------------------------------------
Ash ----------------------------------------------------------------------------------------------------
RCV-A1  ----------------------------------G-I-------E----------------------------------------------V--------
210       220       230       240       250       260       270       280       290       300
|         |         |         |         |         |         |         |         |         |
FR-88   PFGGSTSAIQVTVETRPSEDFEFVMIRAPSSKTVDSISPAGLLTTPVLTGVGNDNRWNGQIVGLQPVPGGFSTCNRHWNLNGSTYGWSSPRFADIDHRRG
SD-89   ----------------------------------------------------------------------------------------------------
05-01   ---------------G------------------------------------------------------------------------------------
Wr-96 --------------------------------------------N------------------------V----------------------------S-
95-10   ----------------------------------------------------------------------------------------------------
Me-93 ----------------------------------------------------------V---------------------------------------S-
99-05   ------N-----------D---------------------------------------------------------------------------------
RCV     ------------------------------------VT--------------T-----C-----------L---------------------T-------
06-11 ------------------------------------V---------------T-------------------------------------S-T-------
Ash ------------------------------------V---------------T-------------------------D-----------S-T-------
RCV-A1  ----T-N--------K---------V----------V---------------T-------------------------------F-------T----P--
310       320       330       340       350       360       370       380       390       400
|         |         |         |         |         |         |         |         |         |
FR-88   SASYSGNNATNVLQFWYANAGSAIDNPISQVAPDGFPDMSFVPFNGPGIPAAGWVGFGAIWNSNSGAPNVTTVQAYELGFATGAPGNLQPTTNTSGAQTV
SD-89   ----P-------------------------------------------------------------------------------------------S---
05-01   ----P------------------V----------------------------------------------------------------------------
Wr-96   ----P-S--------------------------------------V-----------------------R------------------------------
95-10   ----P-S----------------V----------------------------------------------------------------------------
Me-93 ----P------------------V----------------------------------------------------------------------------
99-05 --------S------------------------------------S-N—-T-------G-----N---AA---------------N--------------
RCV     .--QP-G-..-------------V----C--------------L---NV-T----------------------------------N----A-----S-I-
06-11 V-TRP-T..-D-------S----TE----------------I-----SV--------------D------------Q-----N--N-V----------V-
Ash V-TRP-T..-D-------S----TE-----I----------I-----SV---------------------------Q--------S------------V-
RCV-A1  ----P-SSG----E----QT-T-T------I---------------TTV-TG------EV---AN-S-Y-G---------T----N-I----S-----V-
410       420       430       440       450       460       470       480       490       500
|         |         |         |         |         |         |         |         |         |
FR-88   AKSIYAVVTGTAQNPAGLFVMASGVISTPN.ANAITYTPQPDRIVTTPGTPAAAPVGKNTPIMFASVVRRTGDVNATAGSANGTQYGTGSQPLPVTIGLS
SD-89   -----------------------------S.--------------------------------------------------------R------------
05-01   -----------G------------I-----.-------------------------------------------------T-------------------
Wr-96 -----------G------------I-----.-------------------------------------------------T--Y----------------
95-10   ------------------------I-----.---------------------------------------------S----S------------------
Me-93 -----------T------------------.-S--------N----------------------------------------------------------
99-05 -----------N---T--------------.-S-V-----------------------------------------A---T-------------------
RCV     -------S--AN-----------------T.-R------------NA------------V----------------E---D-------------------
06-11 -------S--S-------------I-----.-T------------NA----------R-V------II-----I--A---S-------------------
Ash -------S--V-------------I-----.-T------------NA----------R-V-------------I--A---S-------------------
RCV-A1  -----G-AN-QN-GT----IL---I-----GPA-T------N---NA----------R-V-------I-----I--G-----------------------
510       520       530       540       550       560       570       580
|         |         |         |         |       |         |         |
FR-88   LNNYSSALMPGQFFVWQLTFASGFMEIGLSVDGYFYAGTGASTTLIDLTELIDVRPVGPRPSKSTLVFNLGGTANGFSYV
SD-89   ------------------------------------------------I-------------------------------
05-01   ------------------------------------------------------------------A-----A-------
Wr-96 -----------------------------------------------------------------------SA-------
95-10   -----------------------------------------L--------------------------------------
Me-93 --------------------------------------------------------------------S----T------
99-05   -------------------------------------------------------------------------T------
RCV     --------T---------N----------N-----------------------I--------T---------ATS-----
06-11 -----------------------------------------------------I--------T----------TS-----
Ash  --------T-----------T--------------------------------I--------T-----************
RCV-A1  --------T---------N-T-------------------SL------S----I--------T----Y----AT------
Fig. 1. Amino acid sequence alignment of the VP60 capsid protein from seven representative pathogenic RHDV strains including the antigenic variant RHDVa, the non-pathogenic
Italian RCV and Australian RCV-A1 strains, the UK Ashington strain and the 06-11 strain characterised in this study. The strain names in a shortened form are explained in Table 2.
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RHDV
RHDVa
Italy RCV/1995
France 06-11/2006
UK Ashington/1998 
Australia RCV-A1/2007
100
99
100
100
94
0.05
Fig. 2. Phylogenetic tree derived for nucleotide sequences of 27 RHDV and 5 antigenic
variant RHDVa strains (detailed in Table 2), the non-pathogenic Italian RCV and
Australian RCV-A1 strains, the UK Ashington strain and the NP-LV 06-11 strain, using
the minimum evolution method. Bootstrap values greater than 70% (for 1000
replicates) are given in italics after each node. The French reference European brown
hare syndrome virus strain EBHSV-GD (accession number Z69620) was used as an
outgroup to root the tree. The RHDV and RHDVa branches are collapsed to highlight the
main genogroups.
399G. Le Gall-Reculé et al. / Virology 410 (2011) 395–402Regarding the VP60 gene sequence, 06-11 is closer to the RCV than to
RHDV or RCV-A1, but the highest nucleotide and amino acid identity
was with the Ashington strain. The majority of the 06-11 amino acid
substitutions are found in the C-terminal half of the VP60 protein
which forms the outer shell of the capsid of the caliciviruses (Laurent
et al., 1994; Neill, 1992; Prasad et al., 1994). This part of the RHDV
capsid contains the main antigenic regions (Barcena et al., 2004;
Capucci et al., 1995; Capucci et al., 1998; Martinez-Torrecuadrada et
al., 1998; Meyers et al., 1991). Within this part, the P2 subdomain
which forms an external loop and includes the regions C and E deﬁned
by Neill (1992) contains determinants for cell binding, host speciﬁcity
and strain diversity (Chen et al., 2004; Tan et al., 2006). The relatively
low sequence similarity between 06-11 and pathogenic RHDV strains
in the P2 subdomain might explain the differences in tropism and
lethality. In addition, following the characterisation of RCV, Lavazza
and Capucci (2008b) suggested that the region C of the capsid for
RHDV could inﬂuence the degree of pathogenicity of the caliciviruses.
The description for the ﬁrst time of a strain that was demonstrated to
be non-pathogenic but also to have signiﬁcant sequence variation
within the region C could reinforce the hypothesis that this region
takes part in viral pathogenicity. In other respects, Esteves et al.
(2008) and more recently Kinnear and Linde (2010) showed a
positive selection that occurs in the outer shell of the RHDV VP60
protein and drives amino acid substitutions at some speciﬁc sites
(named positively selected codons or PSCs) within regions where the
main antigenic determinants were described. These authors therefore
suggested that variation of a PSC is likely to be related to
pathogenicity and virulence. Amino acid differences observed in the
06-11 sequence at some of the identiﬁed PSCs (aa 307 and 432), and
notably in the region C of the capsid, seems to conﬁrm their
importance in the antigenic diversity within the Caliciviridae.
The 06-11 strain represents a new NP-LV clustered into the
Ashington lineage and close to RCV. The Ashington strain was
supposed to be pathogenic according to Moss et al. (2002) but ithas never been implicated in any other recognisable epidemic
outbreak in the UK (Forrester et al., 2009). Its close relationship
with the 06-11 strain could suggest that this strain is non-lethal and
experimental conﬁrmation or invalidation of its pathogenicity would
be very useful to understand the genetic evolution of these two
viruses. Indeed, the phylogenetic tree topology suggested that the
RCV and the 06-11/Ashington lineage emerged long before the
divergence of the pathogenic RHDV lineage, with the RCV emerging
prior to the 06-11/Ashington lineage in agreement with previous
published results (Kerr et al., 2009; Moss et al., 2002). In addition, our
results showed a signiﬁcant genetic variation between 06-11 and
Ashington indicating that these two strains may possibly have
evolved independently. Regarding the two other divergent Lambay
and Pit-WD strains described in the UK (Forrester et al., 2007, 2009),
although only one third of their VP60 sequence is known, results also
showed a high genetic variation between 06-11 and these two strains,
especially with the latter (only 85.6% amino acid similarity). All these
data indicate considerable divergence between these different NP-LV
strains. The mean time to the most recent common ancestor (TMRCA)
of RHDV and NP-LV strains was estimated to be over 80 (Kinnear and
Linde, 2010) or 200 years ago (Kerr et al., 2009). In the only study that
includes the Ashington strain in its analyses, the mean TMRCAs of the
Ashington and Australian RCV-A1 strains fall in the 19th century (Kerr
et al., 2009). The authors correlated this time with the date of
introduction of domestic European rabbits to Australia and the
resulting presence of RCV-A1. However, our phylogenetic results
show that the RCV-A1 lineage diverged long prior to the 06-11/
Ashington one. It would be interesting to carry on screening for NP-LV
strains in European countries to identify a virus closer to RCV-A1,
which would be more likely to be at the source of the Australian virus.
These data conﬁrm the circulation of several different non-
pathogenic lineages and highlight the extent of diversity within the
lagovirus genus. Moreover, among this high diversity, our results
show the existence of a gradient of cross-protection between strains.
Indeed, whereas we have demonstrated the existence of NP-LV
strains, previous studies have shown partial cross-protection between
RHDV and RCV-A1 viruses, low titres being non-protective (Cooke et
al., 2002; McPhee et al., 2009; Strive et al., 2010). Cross-protection is
complete with RCV (Capucci et al., 1996) or between RHDV viruses as
shown by the efﬁcacy of vaccine strains. To better understand RHDV
epidemiology in wild populations, besides taking into account factors
such as population size and climate (Cooke et al., 2002; Mutze et al.,
1998; Parkes et al., 2002), host genetics (Guillon et al., 2009), and
virulence of viral strains (Fouchet et al., 2009), we need to determine
to what extent NP-LV strains fail to induce protective immunity
against RHDV. Indeed, differences of cross-protection might explain
the described variability of the impact of RHD on rabbit populations.
The existence of non-protective strains as well as the evidence of
recombination between strains (Abrantes et al., 2008; Forrester et al.,
2008) should lead to reconsideration of the interaction between
pathogenic and non-pathogenic strains, which is likely to be more
complex than previously assumed. Studies are underway to identify
the full-length genome sequence of 06-11 strain. Complete molecular
data on a non-pathogenic and non-protective lagovirus should enable
understanding of RHDV evolution through a comparison with data
already available on some RHDVs (Forrester et al., 2008) and on the
evolutionarily earlier RCV-A1 lineage (Strive et al., 2009).
Materials and methods
Animals
Sixty 10-week-old New Zealand White rabbits showing no
apparent sign of disease were placed in quarantine into several
hutches in two distinct locations of several kilometres far away each
other (“AR” and “JA”; Table 1) before being used in an experimental
400 G. Le Gall-Reculé et al. / Virology 410 (2011) 395–402assay in the ﬁeld as sentinel animals. The rabbits were raised without
vaccination against RHDV or myxomatosis in a controlled small
rabbitry which had maintained good sanitary conditions for several
years. To determine their serological status against RHDV, sera were
collected onto blotting paper twice, 1 week apart, at D0 and at D6, and
blood samples were screened for the presence of RHDV antibodies.
Sera from the seronegative or seropositive with low titre rabbits at D6
were collected again at D13.
To attempt to identify NP-LV viruses, we sacriﬁced rabbits at the
beginning of the seroconversion to collect liver, spleen and small
intestine (duodenum) samples. We therefore sacriﬁced at D13 24
rabbits among those that were seronegative or seropositive with low
or moderate antibody titres at D0, and sacriﬁced at D21 ﬁve rabbits
that were seronegative or having low titres at D6. The other 31 rabbits
were kept in the hutches.
Antibody detection
A VP60-RHDV ELISA based on the detection of a baculovirus-
expressed capsid protein (VP60) antigen that self-assembles into
virus-like particles (Laurent et al., 1994) was used for semi-
quantitative measurement of the antibody titres according to the
method described in Marchandeau et al. (2005). A serum was
considered to be negative when the ratio sample OD405 (optical
density)/negative control OD405 was below 3, positive with low titre
(+)when the ratio was between 3 and 4, positive withmoderate titre
(++) when the ratio was between 4 and 6, positive with high titre
(+++) when the ratio was between 6 and 8, and positive with very
high titre (++++) when the ratio was above 8. As this ELISA does
not enable discrimination of antibodies due to RHDV infection from
those due to RHDV-like infections (Marchandeau et al., 2005), some
positive sera (n=24) were also screened with a competitive ELISA
(cELISA) and anti-isotype ELISA tests (Capucci et al., 1997) as
described in Cooke et al. (2000, 2002) and Lavazza and Capucci
(2008a). The cELISA recognises an external epitope speciﬁc to RHDV
(Capucci et al., 1997). This test using a monoclonal antibody is
considered as the standard, reference serological test for RHD
(Lavazza and Capucci, 2008a). The anti-isotype ELISA tests detect
IgM, IgG and IgA speciﬁc to RHDV. They are used to interpret ﬁeld
serology and to determine the immunological status of rabbits
(Lavazza and Capucci, 2008b; Cooke et al., 2002). The use of these
different tests makes it possible to detect a large range of antibodies
raised against rabbit lagoviruses and to discriminate antibodies raised
against RHDV from those raised against other rabbit lagoviruses.
RT-PCR and sequence analysis
Each frozen liver sample was thawed and 100 μl of the obtained
exudate was collected. For the other tissue samples (duodenum and
spleen), 30 mg was homogenised using a mixer-mill disruptor
(TissueLyser, QIAGEN). RNAs were extracted using the RNeasy Mini
kit (QIAGEN) and viral RNAs were reverse transcribed using oligo-dT
(Invitrogen) as a primer and SuperScript™ II Reverse Transcriptase
(Invitrogen).
For the initial screening, several pairs of RHDV primers for
polymerase chain reaction (PCR) ampliﬁcation were used, among
which were three pairs previously deﬁned to amplify overlapping
genomic regions of the gene encoding the VP60 (Le Gall-Reculé et al.,
2003). Two successive ampliﬁcations with the same PCR primers
using the AmpliTaq Gold® DNA polymerase (Applera Applied
Biosystems) were necessary to obtain sufﬁcient quantities of DNA to
allow their sequencing. The ampliﬁed PCR products were visualised
by electrophoresis on agarose gel and puriﬁed (UltraClean™ 15 DNA
Puriﬁcation Kit, Mo Bio Laboratories) prior to sequencing. The DNA
sequence was determined twice in both directions by the dye
terminator method (ABI PRISM DyeTerminator Cycle SequencingReady Reaction kit, Applera Applied Biosystems) on an ABI 373XL
automatic DNA sequencer (Applera Applied Biosystems) with the PCR
primers and sequencing primers (Le Gall-Reculé et al., 2003). To
conﬁrm the assembled VP60 gene sequence, positive cDNAs were
subjected to one run of full-length VP60 PCR ampliﬁcation using a
speciﬁc primer pair designed from the preliminary NP-LV VP60 gene
sequences we obtained. A high-ﬁdelity DNA polymerase (Expand
High FidelityPLUS PCR System, Roche Applied Science) was used. The
DNA sequence was determined using PCR and sequencing primers as
described above (primer sequences available upon request). The
deduced amino acid sequences of the VP60 gene were obtained using
the software available on the Biosupport website. Multiple amino acid
sequence alignments were generated by the CLUSTALWmethod using
the NPS website.
Following RHDV infections, RNAwas extracted from liver exudates
using a commercial kit (RNeasy Mini kit, QIAGEN) and tested for
RHDV RNA by RT-PCR as described by Le Gall-Reculé et al. (2003).
Screening for NP-LV RNA was performed from duodenum samples as
described in the previous paragraph, except that RNAwas extracted in
a preliminary step with TRIzol® Reagent (Invitrogen) before the use
of “RNeasy” columns to increase the sensitivity. For the screening of
positive samples, we used a pair of PCR primers (“U38” 5'
CAGCGGGCACTGCTACCACAGCATC 3' and “L337” 5' GAAGCGAAACTG-
CATGCCACCRGCCCA 3') derived from the one (Rab1b-Rab2) deﬁned
by Tanja Strive (CSIRO, Australia) who kindly provided us with the
sequences before their publication (Strive et al., 2009). Then, the full-
length VP60 PCR ampliﬁcation was performed.
Phylogenetic analyses
Phylogenetic relationships were inferred using entire sequences of
the capsid protein VP60 gene available in databases from some
representative pathogenic RHDV and the antigenic variant RHDVa
(Capucci et al., 1998), the non-pathogenic Italian RCV strain and the
non-pathogenic lagovirus RCV-A1 recently characterised in Australia.
We also included the sequence of the divergent Ashington strain from
the UK since it is almost complete (95% of the gene). The accession
number, country of origin and year of collection of the 36 sequences
are listed in Table 2. The sequence of the French reference European
brown hare syndrome virus (EBHSV) strain EBHSV-GD (accession
number: Z69620 (Le Gall et al., 1996)) was used as an outgroup to
root the trees. Phylogenetic analyses were conducted using MEGA
software version 3.1 (Kumar et al., 2004) for phenetic and cladistic
characterisation. Multiple sequence alignments were generated by
the CLUSTALW method. For the phenetic analysis, the Minimum
Evolution (ME) method was implemented with the Kimura 2-
parameter model including transition and translation substitutions.
The search for the ME tree was implemented with the close-
neighbour-interchange option and the Neighbour-joining algorithm
was used to generate the initial tree. For the cladistic method,
Maximum Parsimony (MP) was used and the search for the MP tree
was implemented with the close-neighbour-interchange algorithm.
For the two methods, codon positions included were the 1st and the
2nd, and the pairwise deletion option was selected. The topology of
trees was evaluated by 1000 bootstrap analyses. Majority-rule
consensus trees were determined by the CONSENSE program and
were drawn using MEGA software version 3.1.
Experimental studies of viral transmission and of protection against
RHDV infection
Two experimental studies were performed under negative
pressure in rooms at BSL2 experimental facilities with ﬁltered air
according to biosafety and bioethical procedures, under the authori-
zation of animal experimentation number 22–24 delivered by the
Table 2
Sequences of RHDV, antigenic variant RHDVa (in italics), RCV, RCV-A1, Ashington and
06-11 strains used for phylogenetic analyses. The country of origin, the name of the
isolate and the year of collection are included in the name when known. The sequence
names are ordered according to their position in the phylogenetic tree.
Name: country isolate/year of collection GenBank/EMBL accession number
(shortened names in Fig. 1)
UK Rainham/1993 AJ006019
France 95-10/1995 (95-10) AJ535094
Germany Frankfurt/1996 Y15424
Italy BS/1989 X87607
Germany Meiningen/1993 (Me-93) Y15426
Germany Hagenow/1990 Y15441
UK Ascot/1992 EF558575
France 95-05/1995 AJ535092
France 00-13/2000 AJ495856
France 05-01/2005 (05-01) AM085133
Barhain/2001 DQ189077
Germany Wriezen/1996 (Wr-96) Y15427
UK Ireland12/2001 AY926883
Saudi Arabia/1996 DQ189078
China WX/1984 AF402614
France Haute-Saone/1988 (FR-88) U49726
Mexico/1989 AF295785
Korea/1990 EU003580
Italy/1990 EU003579
Germany FRG/1989 M67473
New Zealand,NZ54/2003 EF558579
New Zealand AF231353
Czech V351/1987 U54983
France 00-08/2000 AJ329594
Germany Eisenhuettenstadt/1989 Y15440
Spain AST/1989 Z49271
France SD/1989 (SD-89) Z29514
Germany Triptis/1996 Y15442
China CD/2004 AY523410
USA Iowa/2000 AF258618
France 99-05/1999 (99-05) AJ302016
France 03-24/2003 AJ969628
Italy RCV/1995 (RCV) X96868
France 06-11/2006 (06-11) AM268419
UK Ashington/1998 (Ash) EF558587
Australia RCV-A1/2007 (RCV-A1) EU871528
401G. Le Gall-Reculé et al. / Virology 410 (2011) 395–402local director of veterinary services on behalf of the prefect of Côtes
d'Armor department.
First, in order to study the transmission route and lethality of the
06-11 strain, two 10-week-old speciﬁc-pathogen-free (SPF) commer-
cial New Zealand White rabbits were used. To test the lethality of the
virus isolated in the rabbitry, one SPF rabbit was inoculated by the
oro-nasal route with ﬁltered (0.22 μm) supernatant of a pool of
duodenum samples from which RHDV-like RNAs had been charac-
terised. In order to study the possibility of viral transmission through
contact, the other SPF rabbit was placed in a cage with three 9-week-
old healthy rabbits taken from the rabbitry. Blood samples were
collected onto blotting paper from the ﬁve rabbits at the beginning of
the assay (D0), then twice 5 days apart (D5 and D10) and at the
sacriﬁce (D14). Detection of antibodies was performed using the
VP60-RHDV ELISA test. Daily observations for morbidity (asthenia,
anorexia, respiratory and nervous signs) and mortality were
performed. Surviving animals were killed humanely and examined
for macroscopic lesions. Duodenum and liver samples were collected
for virological analyses.
Second, in order to determine whether the detected 06-11
antibodies conferred cross-protection to rabbits against subsequent
RHDV infection, ﬁve rabbits exhibiting very high titres of antibodies
were selected for an experimental challenge (Table 1). Theywere split
into two groups: (i) three rabbits were challengedwith a standardised
intramuscular inoculation of 103 LD50 of RHDV reference strain
isolated in 1988 in France and (ii) two rabbits were placed in an open
wire-meshed cage adjacent to that of inoculated rabbits that allowed
direct contact between the rabbits to favour infection by a naturalroute. Daily observations for morbidity (asthenia, anorexia, respira-
tory and nervous signs) and mortality were performed. Dead rabbits
were examined for macroscopic lesions and liver samples were
collected for virological analyses.Nucleotide sequence accession number
The nucleotide sequence of the NP-LV strain 06-11 is available in
databases under the GenBank/EMBL accession number AM268419.Acknowledgments
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